4
Changes in Ownership
ARTIVION, INC. Filed Acc 0001628280-25-053702
SVP, Clinical & MD Affair sold 15,276 shares at an average $44.18 ($674,825)
- SVP, Clinical & MD Affair acquired 3,388 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stanton Marshall S. SVP, Clinical & MD Affair | 2025-11-20 | Sale | −11,888 | $44.14 | $524,736 | 44,753 | D |
| Stanton Marshall S. SVP, Clinical & MD Affair | 2025-11-20 | Option exercise | +2,033 | $18.44 | $37,489 | 46,786 | D |
| Stanton Marshall S. SVP, Clinical & MD Affair | 2025-11-20 | Sale | −2,033 | $44.32 | $90,092 | 44,753 | D |
| Stanton Marshall S. SVP, Clinical & MD Affair | 2025-11-20 | Option exercise | +1,355 | $11.03 | $14,946 | 46,108 | D |
| Stanton Marshall S. SVP, Clinical & MD Affair | 2025-11-20 | Sale | −1,355 | $44.28 | $59,997 | 44,753 | D |
| Derivatives | |||||||
| Stanton Marshall S. SVP, Clinical & MD Affair | 2025-11-20 | Option exercise · Stock Options (Right to buy) | −2,033 | 20,301 | D | ||
| Stanton Marshall S. SVP, Clinical & MD Affair | 2025-11-20 | Option exercise · Stock Options (Right to buy) | −1,355 | 27,075 | D | ||
| Open-market sales · 15,276 sh · avg $44.18 · $674,825 | |||||||
Loading xslF345X05/wk-form4_1763994956.xml…